Last reviewed · How we verify
Supraventricular arrhythmia
Approved treatments
- Ajmalin
Ajmaline works by blocking potassium channels in the heart to help regulate heart rhythm. - Etacizin
Etacizin works by blocking potassium channels in the heart, which helps to regulate abnormal heart rhythms. - Tachmalcor
Tachmalcor works by stabilizing cardiac ion channels to regulate abnormal heart rhythms. - Fiboran
- Triphosphoric Acid Adenosine Ester
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Supraventricular arrhythmia patent landscape — cliff calendar, originator estates, attackable patents
- Supraventricular arrhythmia treatment landscape brief
- Supraventricular arrhythmia treatment updates RSS
Frequently asked questions about Supraventricular arrhythmia
What drugs treat Supraventricular arrhythmia?
Tracked treatments include Ajmalin, Etacizin, Tachmalcor, Fiboran, Triphosphoric Acid Adenosine Ester.
What is the treatment for Supraventricular arrhythmia?
Standard treatment for Supraventricular arrhythmia includes Ajmalin, Etacizin, Tachmalcor, Fiboran, Triphosphoric Acid Adenosine Ester. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Supraventricular arrhythmia patent cliff · Supraventricular arrhythmia CI report
- Treatment: Ajmalin
- Treatment: Etacizin
- Treatment: Tachmalcor
- Treatment: Fiboran
- Treatment: Triphosphoric Acid Adenosine Ester
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing